Market Closed -
Hong Kong S.E.
01:38:20 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
2.72
HKD
|
+0.74%
|
|
+4.21%
|
-27.08%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
15,649
|
17,061
|
9,872
|
10,273
|
11,474
|
9,471
|
9,471
|
-
|
Enterprise Value (EV)
1 |
20,114
|
19,939
|
15,881
|
16,937
|
15,546
|
12,753
|
12,418
|
12,054
|
P/E ratio
|
11.8
x
|
11.4
x
|
13.7
x
|
-74.4
x
|
18.6
x
|
23.7
x
|
15.6
x
|
11.8
x
|
Yield
|
2.09%
|
2.17%
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.02
x
|
2.68
x
|
1.78
x
|
1.98
x
|
1.92
x
|
2.08
x
|
1.4
x
|
1.22
x
|
EV / Revenue
|
3.89
x
|
3.14
x
|
2.87
x
|
3.26
x
|
2.6
x
|
2.08
x
|
1.83
x
|
1.55
x
|
EV / EBITDA
|
11.6
x
|
7.81
x
|
8.46
x
|
18.7
x
|
8.58
x
|
6.14
x
|
6.87
x
|
6.59
x
|
EV / FCF
|
6,33,66,390
x
|
2,57,43,540
x
|
4,66,21,206
x
|
-4,53,07,565
x
|
3,16,99,228
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
-0%
|
0%
|
-
|
-
|
-
|
Price to Book
|
1.97
x
|
1.81
x
|
1.23
x
|
1.18
x
|
1.11
x
|
0.77
x
|
0.73
x
|
0.69
x
|
Nbr of stocks (in thousands)
|
32,69,965
|
32,68,965
|
32,48,965
|
35,41,372
|
35,49,671
|
37,61,671
|
37,61,671
|
-
|
Reference price
2 |
4.786
|
5.219
|
3.038
|
2.901
|
3.232
|
2.518
|
2.518
|
2.518
|
Announcement Date
|
28/03/19
|
26/03/20
|
31/03/21
|
29/03/22
|
29/03/23
|
27/03/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
5,173
|
6,358
|
5,540
|
5,200
|
5,982
|
6,143
|
6,789
|
7,782
|
EBITDA
1 |
1,733
|
2,553
|
1,877
|
906.9
|
1,813
|
2,077
|
1,809
|
1,830
|
EBIT
1 |
1,422
|
1,729
|
961.2
|
-6.49
|
747.6
|
872.9
|
1,065
|
1,235
|
Operating Margin
|
27.5%
|
27.2%
|
17.35%
|
-0.12%
|
12.5%
|
14.21%
|
15.69%
|
15.87%
|
Earnings before Tax (EBT)
1 |
1,473
|
1,772
|
942.2
|
-74.56
|
669.8
|
700.1
|
767.3
|
962.9
|
Net income
1 |
1,303
|
1,469
|
706.6
|
-134.4
|
604.8
|
532.6
|
657.8
|
930.8
|
Net margin
|
25.19%
|
23.1%
|
12.76%
|
-2.58%
|
10.11%
|
8.67%
|
9.69%
|
11.96%
|
EPS
2 |
0.4045
|
0.4584
|
0.2212
|
-0.0390
|
0.1738
|
0.1429
|
0.1614
|
0.2137
|
Free Cash Flow
|
317.4
|
774.5
|
340.6
|
-373.8
|
490.4
|
-
|
-
|
-
|
FCF margin
|
6.14%
|
12.18%
|
6.15%
|
-7.19%
|
8.2%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
18.31%
|
30.34%
|
18.15%
|
-
|
27.05%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
24.35%
|
52.74%
|
48.21%
|
-
|
81.09%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1000
|
0.1130
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/03/19
|
26/03/20
|
31/03/21
|
29/03/22
|
29/03/23
|
27/03/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
3,131
|
3,227
|
2,962
|
2,577
|
2,952
|
2,249
|
2,851
|
3,131
|
2,904
|
3,239
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-
|
-
|
521.8
|
589.5
|
300.6
|
-
|
-294.8
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
23.2%
|
20.68%
|
9.6%
|
-
|
-9.1%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.2382
|
0.2202
|
0.1686
|
0.0526
|
0.1129
|
-0.1519
|
0.0854
|
0.0884
|
0.0406
|
0.1023
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/08/19
|
26/03/20
|
27/08/20
|
31/03/21
|
29/08/21
|
29/03/22
|
29/08/22
|
29/03/23
|
29/08/23
|
27/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
4,465
|
2,878
|
6,009
|
6,665
|
4,072
|
3,669
|
2,947
|
2,583
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.576
x
|
1.127
x
|
3.201
x
|
7.349
x
|
2.246
x
|
2.496
x
|
1.629
x
|
1.411
x
|
Free Cash Flow
|
317
|
775
|
341
|
-374
|
490
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
17.9%
|
17.2%
|
10.9%
|
-1.64%
|
6.48%
|
6.1%
|
4.73%
|
5.86%
|
ROA (Net income/ Total Assets)
|
9.21%
|
7.97%
|
4.56%
|
2.03%
|
-
|
-
|
-
|
-
|
Assets
1 |
14,150
|
18,426
|
15,497
|
-6,614
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.430
|
2.880
|
2.480
|
2.460
|
2.920
|
3.290
|
3.460
|
3.670
|
Cash Flow per Share
|
0.3200
|
0.5400
|
0.3200
|
0.0500
|
0.4800
|
-
|
-
|
-
|
Capex
|
728
|
970
|
693
|
556
|
1,163
|
-
|
-
|
-
|
Capex / Sales
|
14.08%
|
15.26%
|
12.51%
|
10.7%
|
19.45%
|
-
|
-
|
-
|
Announcement Date
|
28/03/19
|
26/03/20
|
31/03/21
|
29/03/22
|
29/03/23
|
27/03/24
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
2.518
CNY Average target price
2.785
CNY Spread / Average Target +10.60% Consensus |
1st Jan change
|
Capi.
|
---|
| -27.08% | 1.31B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|